Add like
Add dislike
Add to saved papers

Safety and efficacy of lateral mass screws at C7 in the treatment of cervical degenerative disease.

BACKGROUND: To evaluate the safety and efficacy of lateral mass screws at C7 in the treatment of cervical degenerative disease.

METHODS: Patients with cervical degenerative disease who underwent posterior cervical fusion and fixation from 2009 to 2015 were included in the study. All complications were captured. Postoperative X-ray and computed tomography (CT) confirmed fusion at 6 and 12 months after surgery. X-ray and CT confirmed screw loosening, misplacement, pull-out, breakage, or rod breakage.

RESULTS: Seventy-two patients underwent cervical laminectomy and fixation with lateral mass screws at C7 and had at least 1 year follow-up. One patient had C3 screw pull-out; revision was not required. There were no complications related to the C7 screws, and all were in the lateral mass.

CONCLUSIONS: Lateral mass screws are as safe and effective as pedicle screws at C7 in long-segment posterior cervical fixation, have a lower rate of perioperative complications than pedicle screws, and are technically easier to place.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app